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ABStrACt 
 
Introduction: Inflammatory bowel disease comprises two major categories: Crohn’s disease and ulcerative rectocolitis, both with different 
clinical and histological aspects, causing sometimes significant morbidity. Objectives: Choose and apply standardized and quantified 
histopathological diagnosis method, and compare the results and quality index with the original diagnosis. Materials and methods: 
43 histological colonoscopic biopsies of 37 patients were re-evaluated by standardized system. Results and discussion: The original 
diagnoses were more inconclusive (23.3%) than those standardized (2.3%). The agreement with gold standard (clinical, colonoscopical, 
and radiological diagnosis) was higher on standardized diagnoses (95.3%) than in original (74.4%), especially in relation to Crohn’s 
disease, which percentages were 92.3% and 46.1%, respectively. The quality index was calculated in conclusive diagnosis of each method. 
For ulcerative rectocolitis, both methods showed sensitivity and negative predictive value of 100%; otherwise the original diagnosis 
demonstrated specificity of 85.7%, positive predictive value of 96.3% and accuracy of 97.0%, and the standardized diagnosis 92.3%, 96.7% 
and 97.6%, respectively. For Crohn’s disease, there is specificity and positive predictive value of 100% in both methods; the original diagnosis 
showed sensitivity of 85.7%, negative predictive value of 96.3% and accuracy of 97%, while for the standardized diagnoses 92.3%, 96.7%, 
and 97.6%, respectively. Conclusion: The standardized diagnosis presented a higher percentage of correct and conclusive diagnoses than 
those presented in the original diagnosis, especially for Crohn’s disease, as well as equal or slightly higher values in some quality index. 
Key words: ulcerative rectocolitis; Crohn’s disease; biopsy; pathology.
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introDuCtion
Inflammatory bowel disease (IBD) is the generic term for a 
specific group of chronic inflammatory disorders of unknown 
origin affecting the gastrointestinal tract, with outbreaks of acute 
exacerbation(10). For not presenting specific pathognomonic signs 
the diagnosis is made by the correlation of clinical symptoms 
with various signals detected on endoscopic, radiological and 
histopathological findings, which are add together to a more 
specific conclusion. Colonoscopy is essential to make possible the 
diagnosis and evaluate the extent, severity and distribution of IBD. 
Information obtained at colonoscopy, associated histopathological 
criteria, providing data for classify IBD in one of its two major 
subgroups: ulcerative rectocolitis (UC) and Crohn’s disease (CD). 
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About 10%-20% of cases are designated as indeterminate IBD, 
which diagnosis cannot be defined as UC or CD(8). The specific 
diagnosis is important to evaluate surgical treatment as well as 
long-term follow up since the UC and DC medical management is 
different as regards the evolution of the disease and the indication 
for surgery. The relative risk of colorectal cancer is highest in 
patients with IBD than in the general population(5, 7).
 
oBJECtivES
Choose and apply standardized and quantified histopathological 
diagnosis method, and compare the results and quality index with 
the original diagnosis.
MAtEriALS AnD MEthoDS
This study was approved by the Research Ethics Committee 
at Hospital de Clínicas-Universidade Federal do Paraná (UFPR), 
under protocol number: 718.137/2003-09, and was recorded 
in Research Database System at UFPR (BANPESQ) under code 
number: 2003005726. Retrospective study was performed on IBD 
of 255 outpatient registers at Hospital de Clínicas at UFPR, in July 
2004. There were 130 patients diagnosed with CD and 125 UC. We 
found 445 histopathological examinations, colonic endoscopic 
biopsies of these patients in files of Department of Pathology. 
Among these, only 43 examinations of 37 patients had all the 
inclusion criteria (some had made  more than one exam that 
met the inclusion criteria). Each test consisted of a series of 5-8 
slides, and each slide assembly (relative to one exam) there was 
9-39 fragments of bowel mucosa. All these material totaled 264 
slides and 846 fragments. For sample selection we established 
the following criteria: 1) patients with active colitis at the time 
of biopsy; 2) clinical diagnosis established; 3) clinical segment of 
at least 12 months; 4) at least five different samples of the colon, 
one of which necessarily rectum. The material was previously 
set in aqueous 10% formalin and submitted for processing. The 
capsules were placed in an automatic tissue processor, which held 
dehydration, diaphanization, impregnation, and embedment in 
paraffin. The specimens were included in paraffin for holding 
samples microtome cuts of 4-5 mm. The material was stained 
with hematoxylin-eosin (HE) and examined under light 
microscopy(2, 19, 22). For histopathological evaluation, the method 
developed by Tanaka et al.(25)  was chosen. It was reproduced 
in Table 1 and 2 just like elaborated by the authors. The data 
in these tables defined criteria H1 to H9, which were marked 
as present (1) or absent (0). From these values were made the 
calculations to IBD and CD, which scores were used to classify 
the cases into the categories described in Table 1 and 2. The 
original histopathological diagnoses of 37 patients included in 
this study (43 exams) were classified as UC or CD when these 
hypotheses were suggested or indicated compatibility with them, 
and classified as inconclusive when these possibilities were 
not expected.
tABLE 1 – Simple criteria for differentiate IBD and  
other forms of colitis (non IBD)
Category Definition SCORE IBD (SIBD) = 2H1+ 3H2 + 3H3 + 2H4 - 4
Definite IBD SIBD ≥ 2 H1: Cryptic atrophy
Probable IBD SIBD = 1 H2: Cryptic distortion
Unknown SIBD = 0 H3: Basal plasmacytosis with intense MMNII
Probable non-IBD SIBD = -1 H4: Paneth cells metaplasia distal to the right 
angle of the colon
Definite non-IBD SIBD ≤ -2
Source: Tanaka et al.(25).
IBD: inflammatory bowel disease; MMNII: monomorfonuclear inflammatory infiltrate.
tABLE 2 – Simple criteria for differentiate CD and UC
Category Definition
Score CD (SCD) = 2H5 + 3H6  
+ 2H7 + 3H8 - 3H9 - 5
Definite CD 1.0 ≤ SCD or EG H5: Segmental distribution of atrophy and 
crypt distortion
Probable CD 0.3 ≤ SCD < 1.0 H6: Segmental distribution of mucin depletion
Underteminate -0.3 < SCD < 0.3
H7: Preservation of mucin at the edges of 
ulcers or crypts surrounded by neutrophils
Probable UC -1.0 < SCD ≤ 0.3
H8: Division of NB* with MMNII focal by NB* 
with MMNII
Definite UC SCD ≤ -1.0
H9: Division of NB* with cryptic atrophy and 
severe MMNII by NB* with severe MMNII
Source: Tanaka et al.(25).
CD: Crohn’s disease; UC: ulcerative colitis; EG: epithelioid granuloma; NB*: number of 
biopsies; MMNII: monomorfonuclear inflammatory infiltrate.
rESuLtS
We selected 253 patients − 107 men (42%) and 146 
women (58%) − from IBD outpatient, classified into 129 
UC (51.0%) and 124 CD (49.0%), which had a total of 445 
subjected to histopathological colon biopsies examination, 
with an average of 1.7 per patient. After surveying the results 
of 445 biopsies, only 43 (9.6%) met the inclusion criteria for 
the present study. Table 3 shows clinical data and diagnosis 
based on gold standard, diagnosis reported during request, 
the histopathological original diagnosis (OD) and reviewed 
standardized diagnoses (RSD), if granulomas are present. 
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tABLE 3 – Main clinical and histopathological data from analyzed exams (43 exams of 37 patients)
Exam Age Gender
Follow 
(years)
Gold standard 
clinical diagnosis
Hypothesis on 
request exam
OD RSD
Presence of  
granuloma in OD
Presence of 
granuloma in RSD
1 15 M 6 CD CD Inconclusive CD No No
2 27 F 8 UC UC Inconclusive UC No No
3 26 F 5 UC UC UC UC No No
4 26 F 5 UC UC UC UC No No
5 22 M 3 CD CD Inconclusive CD Yes Yes
6 19 F 6 UC UC UC UC No No
7 30 F 9 UC UC UC UC No No
8 30 F 2 UC UC UC UC No No
9 41 M 1 CD CD Inconclusive CD No Yes
10 45 F 21 UC UC UC UC No No
11 20 F 3 UC UC UC UC No No
12 27 M 1 UC UC UC UC No No
13 25 F 2 UC UC UC UC No No
14 24 M 1 UC UC UC UC No No
15 32 M 17 UC UC UC UC No No
16 36 F 11 UC UC UC UC No No
17 31 F 4 UC UC UC UC No No
18 47 M 14 UC UC UC UC No No
19 50 F 13 UC UC Inconclusive UC No No
20 29 M 5 UC UC UC UC No No
21 30 F 6 UC UC UC UC No No
22 41 F 5 CD CD CD CD Yes Yes
23 50 F 13 UC UC Inconclusive UC No No
24 15 M 6 CD None CD CD Yes Yes
25 37 F 8 CD CD Inconclusive UC No No
26 36 M 7 CD CD Inconclusive CD No No
27 41 F 11 UC UC UC UC No No
28 14 M 5 CD CD CD CD Yes Yes
29 17 F 5 UC UC UC UC No No
30 15 M 5 CD CD UC CD No Yes
31 27 F 7 UC UC UC UC No No
32 23 M 8 CD CD Inconclusive CD No Yes
33 22 F 5 UC UC UC UC No No
34 37 M 9 UC UC UC Inconclusive No No
35 20 M 9 CD CD CD CD No Yes
36 36 F 6 CD CD CD CD Yes Yes
37 57 F 4 CD CD CD CD Yes Yes
38 23 F 8 UC UC UC UC No No
39 15 F 13 UC UC Inconclusive UC No No
40 23 M 5 UC UC UC UC No No
41 43 M 14 UC UC UC UC No No
42 42 M 10 UC CD UC UC No No
43 44 M 14 UC UC UC UC No No
Average 25  - 6 -  - - - - -
Total - - - - - - - 6 (46.1%) 10 (76.9%)
OD: original diagnosis; RSD: reviewed standardized diagnoses; M: male; F: female; CD: Crohn’s disease; UC: ulcerative colitis.
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All RSD were classified as definite for one out of the two 
diseases (CD or UC), except for case 34 that was classified 
as inconclusive. These 43 exams were discriminated in 30 
(69.8%) UC diagnoses, and 13 (30.2%) CD diagnoses. 37 
patients presented 43 exams, which were categorized in 25 
(67.6%) UC and 12 (32.4%) CD (there was more than one 
examination for the same patient included in the study). 
From these 37 patients, 16 (43.2%) were male, and 21 (56.8%) 
female. From 25 patients with UC, 8 (32.0%) were male, and 17 
(68.0%) female. From the 12 individuals with CD, 8 (66.7%) 
were male, and 4 (33.3%) female. Patients were diagnosed 
with IBD at 4-57 years of age, mean 25 years ± 10,1. The 
comparison between OD and RSD regarding the percentage of 
exams with conclusive and inconclusive diagnoses is presented 
in Table 4. To compare OD and RSD results in percentages 
of assertiveness and conclusiveness of diagnosis, binomial test 
was applied, since each sample was evaluated by two diagnostic 
methods (OD and RSD), determining the result classified into 
two categories. Values of p  < 0.05 were considered statistically 
significant. The binomial test results indicated rejection of 
the null hypothesis at a significance level of 5% (p = 0.0117), 
this allows us to affirm that there is a statistically significant 
difference between OD and RSD in relation to the percentage 
of exams with inconclusive diagnoses. Table 4 shows that the 
percentage of tests considered inconclusive by OD (23.3%) is 
higher than the well regarded by RSD (2.3%). The assessment 
of the proportion of cases with correct diagnosis by OD and RSD 
for each disease (UC and CD) is presented in Table 5. For UC, 
the test result indicated the non-rejection of the null hypothesis 
at a significance level of 5% (p = 0.1250). Thus, it can be stated 
that there is no statistically significant difference between OD 
and RSD in relation to the percentage of samples with correct 
diagnoses for UC. For CD, the test result indicated rejection of the 
null hypothesis at a significance level of 5% (p = 0.0313). Thus, 
it can be stated that there is a statistically significant difference 
between OD and RSD in relation to the percentage of samples 
with correct diagnoses for CD. Table 5 shows that the percentage 
of correct cases by RSD (92.3%) is higher than the percentage 
for OD (46.1%). The results of the quality rates for the conclusive 
diagnoses obtained by OD and RSD are shown in Table 6.
tABLE 6 –  Quality indices and their estimated 95%  
interval of confidence obtained from OD and RSD
Quality indices
OD (%) RSD (%)
UC CD UC CD
Sensibility 100
85.7  
(59.8, 100)
100
92.3  
(77.8, 100)
Specificity
85.7  
(59.8, 100)
100
92.3  
(77.8, 100)
100
Positive  
predictive value
96.3  
(89.2, 100)
100
96.7  
(90.2, 100)
100
Negative  
predictive value
100
96.3  
(89.2, 100)
100
96.7  
(90.2, 100)
Accuracy
97.0  
(91.1, 100)
97.0  
(91.1, 100)
97,6  
(93.0, 100)
97.6  
(93.0, 100)
OD: original diagnosis; RSD: reviewed standardized diagnosis; UC: ulcerative colitis;  
CD: Crohn’s disease. 
 
tABLE 4 – Distribution of diagnosis as  
conclusive or inconclusive (n = 43 exams)
 Diagnosis OD RSD
Conclusive 33 (76.7%) 42 (97.7%)
Inconclusive 10 (23.3%) 1 (2.3%)
Total (exams) 43 43
OD: original diagnosis; RSD: reviewed standardized diagnosis.
tABLE 5 – Comparison of OD and RSD in relation to  
the percentage of cases with correct diagnosis of UC and CD
Diagnosis
Gold standard
UC CD
OD RSD OD RSD
Correct 26 (86.7%) 29 (96.6%) 6 (46.1%) 12 (92.3%)
Incorrect(*) 4 (13.3%) 1 (3.3%) 7 (53.8%) 1 (7.7%)
Total 30 30 13 13
OD: original diagnosis; RSD: reviewed standardized diagnosis; UC: ulcerative colitis;  
CD: Crohn’s disease. 
Incorrect(*): inconclusive or incorrect in relation with gold standard.
DiSCuSSion
Inconclusive diagnoses such as “chronic inflammation” 
and “nonspecific inflammation” are of limited value for 
both the physician and the pathologist(11, 28), and despite the 
clinicopathological correlation be the goal of histopathology, it is 
not always possible because the information is not available, or 
clinical data provided contradict the histopathological findings. In 
these cases, the pathologist needs to extract as much information 
as possible from the biopsy. For an appropriate evaluation of biopsy 
in IBD, the pathologist should be informed about the duration of 
symptoms and what kind of treatment was given to the patient 
because the treatment can produce patchiness or discontinuity 
of mucosal inflammation in UC making a differential diagnosis 
more difficult(10). Another study refers that the treatment of UC 
can lead to partial cure, which results in focal lesions simulating 
distribution of CD(29). This fact has already been reported(14) 
highlighting the focal distribution of the lesions in the UC 
treated. The treatment can produce a variety of changes including 
normalization of the mucosa. Some authors emphasize that the 
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information about therapeutics should be given to the pathologist 
avoid misdiagnosis(17, 18, 27). Other authors state that only the 
epithelioid granulomas without ruptured crypts and or chronic 
active ileitis are features highly suggestive of CD on mucosal 
biopsy analysis and that some UC exams may show discontinuous 
disease, no rectal disease, inflammation in ileum, extracolonic 
involvement, granulomatous inflammation, aphthous ulcers 
or mural inflammation. In these cases, the differential diagnose 
with CD can be almost impossible(30). In the appropriate clinical 
presentation the presence of granuloma inflammation in 
gastrointestinal biopsy specimens confirms the diagnosis of 
CD(16, 32), and when the granuloma is not found, the diagnoses of 
CD should be suggested emphasizing the necessity of correlation 
with others clinical, endoscopic and imaging features(9). In a study 
the evaluation of mucosal biopsy in patients with CD demonstrated 
increased numbers of macrophages and microgranulomas 
with the help of the technique of immunohistochemistry for 
CD68+(31).  Another difficulty is the presence of granulomas 
related with crypts ruptures. To distinguish between epithelioid 
granuloma and a granulomatous lesion by rupture of crypt, cuts 
in multiple tissue levels may be necessary to find the presence 
of neutrophils, lymphocytes, and foamy macrophages that are 
absents in the former(30).
In the present study, the histopathological diagnosis was 
correct and conclusive in OD at 74.4% of patients, and in 97.7% 
RSD, demonstrating that the last one increased correlation with 
the gold standard for diagnosis. This percentage was also higher 
than those found by several studies(6, 15, 20, 21, 27, 28) in which the 
correlation was 94%, 80%, 75%, 72%, 73%, and 73% respectively. 
Our hypothesis that the standardized histopathological diagnosis 
increases the correlation with the gold standard in IBD was 
supported on two other studies(3, 13). There is several studies on 
determining the histopathological criteria more discriminately, 
and on how better applying them to the diagnosis of IBD. In some 
studies, the criteria are repeated, consolidating its importance in 
the diagnosis of IBD, as occurred, for example, with the alteration 
in cryptic architecture, which is present in seven reviewed 
studies(6, 13, 15, 21, 23, 24, 27). The authors of the study that was used 
as a model for the standardization review of cases evaluated(24) 
observed that basal plasmacytosis (Figure 1) associated with 
severe inflammatory infiltrate is more discriminative than 
plasmocytosis considered individually. They also observed that 
the diffuse crypt atrophy (Figure 2B) is characteristic of UC, 
whereas segmental atrophy is related with CD. Figure 2A shows 
a comparison between a normal mucosa and a mucosa with 
crypt atrophy. However, they did not consider cryptic abscesses 
and cryptitis discriminative for the differential diagnosis between 
UC and CD, contradicting what other authors have stated(13, 15, 21, 
figurE 1 – Basal plasmacytosis: presence of numerous plasma cells between the 
crypt base (●) and muscularis mucosa ( ■) (HE, lens 400×)
HE: hematoxylin-eosin.
figurE 2A – Normal colonic mucosa with crypts ( ■) tubular, parallel, 
straight, and juxtaposed to the muscularis mucosa (●) (HE, lens 40×)
HE: hematoxylin-eosin.
figurE 2B – Crypt atrophy characterized by tortuosity, scarcity and shortening 
of the crypts ( ■) which basis is far from muscularis mucosa (●) (HE, lens 40×)
HE: hematoxylin-eosin.
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27, 28). Paneth metaplasia (Figure 3) was not analyzed in some 
studies(13, 20, 21), but was analyzed and considered important in six 
other studies(6, 24-28). In the studies reviewed, the histopathological 
findings were evaluated taking into account different criteria. The 
study we have chosen as model for standardized review, assessed 70 
criteria (the largest number of criteria among the studies reviewed), 
which were tested and selected by statistical calculations(24). The 
series of three studies of these authors(24-26) consisted of 431, 726, 
and 60 cases respectively. Together, it is the largest study that used 
the same criteria for IBD biopsies histopathological evaluation. 
In the present study, only one case of CD (number 25 in 
Table 3) was diagnosed as UC by RSD. In this case, we observed that 
rectal mucosa was compromised, there was diffuse distribution of 
atrophy and crypt distortion (Figure 4) (criterion H5), segmental 
distribution of mucin depletion (criterion H6) and preservation of 
mucin in areas of acute inflammation (criterion H7). A conflict 
was observed in the histopathological criteria in this case: the 
diffuse and continuous distribution of cryptic changes from 
the rectum is characteristic of UC according to some authors 
observations(23, 24). Another unusual feature found in this CD case 
was the commitment of the rectum, which is usually spared in 
CD(12). The case inconclusive by RSD (number 34 in Table 3) was 
defined by the gold standard as UC, but it presented: segmental 
distribution of crypt architectural changes (criterion H5), 
segmental distribution of depletion of mucus (criterion H6), and 
focal inflammation, which are histopathological characteristics of 
CD(23, 24). On this exam request there was no information about the 
patient being in treatment at the time of biopsies, even though it 
has endoscopic appearance of UC, but with segmental distribution. 
In biopsies of children with UC, architectural distortion of crypts 
occurs in 32.1%, while it happens in 57.9% of adults(29). The 
authors correlate this difference with the shorter duration of 
disease before biopsy in pediatric cases. There is a contradiction 
between the observations of some studies(23, 29) about the time 
for the appearance of architectural changes promoted by IBD. A 
study argues(23) that they are precocious and can be detected in 
biopsies from patients with seven days of onset of disease activity, 
and moreover the architectural changes are the most important 
in the diagnosis of IBD histopathology, once it differ in each type 
of IBD: diffuse for UC, and focal for CD. These authors also note 
that these changes are not exclusive to IBD as they can be found in 
intestinal amebiasis and shigellosis cases, depending on the strain 
and duration of infection (greater than one week). The quality 
scores obtained by OD and RSD in the present research were not 
consistent with one study(4). Here RSD presented specificity, positive 
predictive value, and accuracy for UC slightly larger than OD. RSD 
also showed sensitivity, negative predictive value, and accuracy 
for CD slightly larger than OD. In conclusive cases the specificity 
for UC and sensitivity to CD (both 92.3%) were higher in RSD 
than in OD (both 85.7%), agreeing with the results of several 
studies(1, 3, 13, 24-27) that consider the standardization of 
histopathological criteria a necessary instrument for improving 
the quality indices of histopathological diagnosis. 
ConCLuSion
RSD diagnosis had a higher percentage of correct and 
conclusive diagnoses than those presented in OD, especially 
statistically significant difference for CD exams. RSD’s conclusive 
cases obtained slightly higher specificity rates, positive predictive 
value, and accuracy for UC; slightly higher sensitivity rates, negative 
predictive value, and accuracy for CD, when compared to OD.
figurE 3 – Paneth cell metaplasia: presence of Paneth cells (●) lined crypts in 
samples after colon right angle (HE, lens 400×)
HE: hematoxylin-eosin.
figurE 4 – Crypt distortion: branching, dilatation, and tortuous crypts ( ■) 
(HE, lens 100×)
HE: hematoxylin-eosin.
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rESuMo 
Introdução: Duas são as formas de manifestação da doença intestinal inflamatória: doença de Crohn e retocolite ulcerativa, 
ambas com evolução clínica, tratamento e aspectos histopatológicos diferentes, causando, por vezes, significativa morbidade. 
Objetivos: Escolher e aplicar método padronizado e quantificado de diagnóstico histopatológico e comparar os resultados e os 
índices de qualidade, com os dos diagnósticos originais. Materiais e métodos: Foram reavaliadas histologicamente 43 biópsias 
colonoscópicas seriadas de 37 pacientes por sistema padronizado. Resultado e discussão: Os diagnósticos originais foram mais 
inconclusivos (23,3%) do que os padronizados (2,3%). A concordância com o padrão-ouro (diagnóstico clínico, colonoscópico e 
radiológico) foi maior nos diagnósticos padronizados (95,3%) do que nos originais (74,4%), principalmente em relação à doença 
de Crohn, cujos percentuais foram de 92,3% e 46,1%, respectivamente. Para retocolite ulcerativa, ambos os métodos apresentaram 
sensibilidade e valor preditivo negativo de 100%; já nos diagnósticos originais, foram verificados especificidade de 85,7%, valor 
preditivo positivo de 96,3% e acurácia de 97%, e nos diagnósticos padronizados, 92,3%, 96,7% e 97,6%, respectivamente. Para 
doença de Crohn, verificaram-se especificidade e valor preditivo positivo de 100% nos dois métodos; nos diagnósticos originais, 
sensibilidade de 85,7%, valor preditivo negativo de 96,3% e acurácia de 97%, e nos diagnósticos padronizados, 92,3%, 96,7% e 
97,6%, respectivamente. Conclusão: O diagnóstico padronizado apresentou maior percentual de diagnósticos corretos e conclusivos 
do que os apresentados no diagnóstico original, principalmente para doença de Crohn, assim como valores iguais ou ligeiramente 
maiores em alguns índices de qualidade. 
Unitermos: retocolite ulcerativa; doença de Crohn; biópsia; patologia.
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